ABVC - ABVC BIOPHARMA, INC.
1.21
-0.110 -9.091%
Share volume: 294,952
Last Updated: 05-09-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.09%
PREVIOUS CLOSE
CHG
CHG%
$1.32
-0.11
-0.08%
Summary score
40%
Profitability
35%
Dept financing
41%
Liquidity
23%
Performance
50%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 2021 - 2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-19.28%
Return on sales
-30817.69%
Return on invested capital
0%
Total debt ratio
54.44%
Debt ratio change over timeo
0%
Current Ratio
0.76%
Quick Ratio
1.45%
Cash Position Ratio
0.19%
Short-term ratios 2024 - 2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-3.97%
Return on sales
-2197.64%
Return on invested capital
0%
Total debt ratio
49.81%
Debt ratio change over timeo
0%
Current Ratio
0.3%
Quick Ratio
0.22%
Cash Position Ratio
0.02%
Last quarter ratios 2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-4.72%
Return on sales
-5775.04%
Return on invested capital
0%
Total debt ratio
63.67%
Debt ratio change over time
0%
Current Ratio
0.22%
Quick Ratio
0.22%
Cash Position Ratio
0.02%
Performance ratios (change over 4 years) 2021 - 2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ABVC | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | 0% | 14.28% | 9.23% | 0% |
| Return on assets | -19.28% | 4.23% | 3.2% | 0% |
| Return on sales | -30817.69% | 27.89% | 25.03% | 0% |
| Return on invested capital | 0% | 8.36% | 9.37% | 0% |
| Profitability | 0% | 97% | 83% | 0% |
| Total debt ratio | 54.44% | 81.28% | 59.58% | 0% |
| Debt ratio change over time | 0% | -11.36% | -57.43% | 0% |
| Dept financing | 42% | 25% | 18% | 0% |
| Current Ratio | 0.3% | 1.23% | 1.12% | 0% |
| Quick Ratio | 0.22% | 0.95% | 0.88% | 0% |
| Cash Position Ratio | 0.02% | 0.12% | 0.5% | 0% |
| Liquididy | 49% | 47% | 67% | 0% |
| Short-term ratios | ABVC | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -3.97% | 4.32% | 3.49% | 0% |
| Return on sales | -2197.64% | 28.32% | 23.63% | 0% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 50% | 41% | 0% |
| Total debt ratio | 49.81% | 81.66% | 60.28% | 0% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 40% | 25% | 18% | 0% |
| Current Ratio | 0.3% | 1.23% | 1.12% | 0% |
| Quick Ratio | 0.22% | 0.95% | 0.88% | 0% |
| Cash Position Ratio | 0.02% | 0.12% | 0.5% | 0% |
| Liquididy | 12% | 56% | 71% | 0% |
